Lars Tönges (@larstoenges) 's Twitter Profile
Lars Tönges

@larstoenges

Professor of Neurology, Expert on #Parkinsons disease

ID: 1090229274693591041

calendar_today29-01-2019 12:44:49

298 Tweet

158 Followers

82 Following

The Lancet (@thelancet) 's Twitter Profile Photo

NEW—Even for the #DeltaVariant, vaccine efficacy against severe #COVID19 so high that booster doses for general population are not appropriate at this stage in the pandemic. Expert review of evidence to date by intl. group of scientists: hubs.li/H0X7tVx0 #VaccinEquity

NEW—Even for the #DeltaVariant, vaccine efficacy against severe #COVID19 so high that booster doses for general population are not appropriate at this stage in the pandemic.

Expert review of evidence to date by intl. group of scientists: hubs.li/H0X7tVx0 #VaccinEquity
Lars Tönges (@larstoenges) 's Twitter Profile Photo

Für alle an neurodegenerativen Erkrankungen, #Parkinson, #Demenz, #ALS Interessierten - 35 spannende Fälle aus der Praxis jetzt im neuen Fallbuch zusammen mit Dr. #Biesalski bei Springer Nature ! amazon.de/Neurodegenerat…

Lars Tönges (@larstoenges) 's Twitter Profile Photo

New Update on #CSF #Biomarkers in #Parkinsons Disease in Biomolecules MDPI Special Issue in Honor of Prof. #Riederer. Is there more than #alpha-Synuclein and #NfL ? mdpi.com/2218-273X/12/2…

Lars Tönges (@larstoenges) 's Twitter Profile Photo

Please check out our new publication w O. Rascol in Parkinsonism & Related Disorders on IR/ER #amantadine treatment in the #Parkinsons #ALLAY-LID studies. Robust anti #dyskinesia effect in #UDysRS scores and increased #ON time (!). Only moderate AE. doi.org/10.1016/j.park…

Lars Tönges (@larstoenges) 's Twitter Profile Photo

Very interesting Special Issue on #alphaSynuclein Amyloids & #Parkinsons Disease: On Growth, Spread, and Neurodegeneration mdpi.com/si/54602 #mdpibiomolecules via Biomolecules MDPI

Lars Tönges (@larstoenges) 's Twitter Profile Photo

Please check out our new #manuscript in Frontiers about #Biomarkers in #Monogenetic Forms of # Parkinsons with Dr. Kwon @RUBMedizin and Prof. Klebe Uni Duisburg-Essen @unidue.bsky.social. Here, biomarkers such as #synuclein will be important for diagnostic / monitoring purposes, too. frontiersin.org/article/10.338…

Lars Tönges (@larstoenges) 's Twitter Profile Photo

Heute letzter Tag des DPG Kongresses #Parkinson und #Bewegungsstörungen Dt. Kongress für Parkinson und Bewegungsstörungen. Gleich #Plenarsitzung Individualisierte Therapien mit Vorträgen über orale Pharmakotherapie, Medikamentenpumpen und Tiefenhirnstimulation. Please join ! dpg-akbont-kongress-2021.de/portal/startse…

Lars Tönges (@larstoenges) 's Twitter Profile Photo

Heute auf dem DPG Kongress #Parkinson und #Bewegungsstörungen Dt. Kongress für Parkinson und Bewegungsstörungen. Individualisierte Therapie bei #Dystonie, #Huntington #Parkinson sowie #THS bei seltenen Bewegungsstörungen mit Kollegen von Uni Duisburg-Essen @unidue.bsky.social, Universität Freiburg und Ruhr-Universität Bochum @RUBMedizin dpg-akbont-kongress-2021.de/portal/startse…

Lars Tönges (@larstoenges) 's Twitter Profile Photo

The pathophysiologic influence of #SARSCoV2 and #COVID19 for #Parkinsons remains an interesting topic with many unsolved questions. Please find our recent review with colleagues from Uni Duisburg-Essen @unidue.bsky.social and Ruhr-Universität Bochum @RUBMedizin now at Brain Sciences MDPI mdpi.com/2076-3425/12/4….

Lars Tönges (@larstoenges) 's Twitter Profile Photo

#Wearable device-based measures increasingly help to evaluate #Parkinsons symptoms including #gait, #balance for #PwP in #PD-MCT. Big thanks to all for a very nice collaboration of Ruhr-Universität Bochum and #Maetzler group from Neurogeriatrics Kiel Universität Kiel CAU 🎓. link.springer.com/article/10.100…

Lars Tönges (@larstoenges) 's Twitter Profile Photo

Very good and comprehensive review about alpha-#Synuclein as a potential biomarker for #Parkinsons and other #synucleinopathies from @Hlashuel and Pedro Magalhães - very worth reading and open access ! 😉

Lars Tönges (@larstoenges) 's Twitter Profile Photo

Happy to have been able to contribute to the #SPARK Study for #Parkinsons, now published in NEJM. There were high hopes for the antibody-based approaches, which unfortunately have failed. Novel trials target PwP and genetic risk - we do not give up ! nejm.org/doi/full/10.10…

Lars Tönges (@larstoenges) 's Twitter Profile Photo

Please join our report about the 2022 Madrid #MDSCongress tonight at 6pm: streamedup-events.com/abbvie-mds/log…. Lots of novel data about #Parkinsons and other movement disorder diseases. Presented together with Prof. Daniel Weiss from Universität Tübingen and Prof. Norbert Brüggemann from Universität Lübeck.

Lars Tönges (@larstoenges) 's Twitter Profile Photo

Please join our 3rd Symposium on #Parkinsons and other #movement_disorders @ St. Josef Hospital #Bochum on Sat Oct 29, 2022. Joint event of Ruhr-Universität Bochum and @NeuroEssen w key note speakers Prof. Klein Universität Lübeck Prof. Storch Universität Rostock. #neurogenetics bit.ly/Ruhr-Symposium…

Lars Tönges (@larstoenges) 's Twitter Profile Photo

Please find our new publication on #Parkinsons and #autonomic dysfunction in @BrainComms. Vagal atrophy in PD correlates with impairment of parasympathetic activity. Very nice collaborative work with colleagues from Ruhr-Universität Bochum. academic.oup.com/braincomms/art…